Biotricity, Inc. (OTCMKTS:BTCY) Sees Significant Decrease in Short Interest

Biotricity, Inc. (OTCMKTS:BTCY) was the recipient of a significant drop in short interest in September. As of September 15th, there was short interest totalling 227,800 shares, a drop of 21.7% from the August 31st total of 291,100 shares. Based on an average trading volume of 40,700 shares, the days-to-cover ratio is presently 5.6 days.

Biotricity Stock Down 9.8 %

Biotricity stock traded down $0.03 during trading on Friday, reaching $0.25. The stock had a trading volume of 66,387 shares, compared to its average volume of 75,328. Biotricity has a 52-week low of $0.24 and a 52-week high of $2.22. The business has a 50 day moving average price of $0.46 and a 200 day moving average price of $0.90. The stock has a market cap of $5.41 million, a PE ratio of -0.19 and a beta of 1.35.

Biotricity (OTCMKTS:BTCY) last released its quarterly earnings data on Monday, August 19th. The company reported ($0.49) earnings per share (EPS) for the quarter. The firm had revenue of $3.20 million for the quarter. On average, equities analysts predict that Biotricity will post -1.43 EPS for the current fiscal year.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.